Results for: gsk Search Results
Family Filter:
Welcome to Graphics Soodhukavvum! A place for animated parody alternate endings to major motion pictures. We make cartoons as fast as we can and hopefully we can make you laugh along the way. Thanks for watching our videos and thank YOU for subscribing. (SUBSCRIBER NEEDS (DO ANYTHING FOR GRAPHICS)
4:39
A Factory Is Born GSK
18 Nov 2009
134
Share Video

2:41
Leading, empowering, changing, giving... the contemporary culture of GSK attracts ambitious and caring talent.
16 Jan 2010
333
Share Video

3:28
One of the nicest things about working for GSK in Philadelphia is that our company has such strong roots in this area. We've been here since 1830! Many of my colleagues are second- or third-generation GSK employees. So it made sense that when we held the grand opening of our new home at the Philadelphia Navy Yard this past weekend, we invited our families to join us in the celebration. Deirdre Connelly, president of North America Pharmaceuticals, welcomed our many esteemed guests (including Mayor Michael Nutter), extending a special welcome to the 'next generation' of GSK employees. We've transformed our workspace and have a variety of settings throughout the building instead of individual offices. Deirdre noted that this work environment might become the norm by the time the next generation takes our jobs. In the meantime, those kids had a great time exploring our new building, getting their faces painted, having their pictures taken, drawing on our meeting room walls, and watching science experiments. The children in attendance were impressed by the coolness of our work environment. The adults in attendance were impressed by the announcement that our building is the first double LEED® platinum certified facility in Philadelphia, which means we earned the highest possible green building rating. As a 15-year-employee, I felt incredibly proud of our company's history in Philadelphia, proud of our commitment to this region, and proud of our efforts to create an environmentally sustainable and collaborative work environment for our employees who work here today and for the children who might be future GlaxoSmithKline employees. I should also add how proud I am that my cousin--an ironworker--helped build our new home at Five Crescent Drive. Every time I walk up and down our grand staircase, I am reminded of the conversations we had while he was working on our building and his promise to make us a beautiful place to work. They certainly did. About GlaxoSmithKline GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information go to us.gsk****, follow us on twitter****/GSKUS or visit our blog(www.morethanmedicine.us.gsk****/blog/). More information about GSK at The Navy Yard is available here: *******us.gsk****/html/media-news/navy-yard-press-kit.html
11 Apr 2013
331
Share Video

3:15
GSK & Save the Children By Michael M, GSK Communications Today, we announced an ambitious new partnership with Save the Children to save the lives of a million of the poorest children in the world. While good progress has been made in recent years, almost seven million children die each year through lack of access to basic healthcare, vaccines or nutritious food. Through these and other initiatives, the partnership aims to help save the lives of one million children in the next five years. We're working together in a very different way--sharing expertise, resources, reach and influence to tackle some of the leading causes of childhood deaths. GSK and Save the Children have been working together for eight years on a number of public health projects, including our initiative to reinvest 20% of the profits we make in the least-developed-countries in community programs to strengthen healthcare infrastructure, primarily through the training of community health workers. We've even sent a number of employees to work with them for extended assignments through our employee volunteer program called PULSE. Ivy, who works in our Philadelphia office, recently returned from a PULSE assignment with Save the Children. Watch her describe why she is so excited about this new collaboration. GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk**** Save the Children - Save the Children works in more than 120 countries and helps to save children's lives, fight for their rights and help them fulfil their potential. For more information visit: www.savethechildren*******
23 May 2013
178
Share Video

0:48
*******www.childrenshealthfund****/about-us/corporate-council/david-pulman - David Pulman took up the position of President, Global Manufacturing and Supply (GMS), GlaxoSmithKline in December 2002. He is a member of the Corporate executive team. Previously, he held the position of Senior Vice President - Strategy, Logistics and North American Supply, GMS, GSK, since January 2001.
15 Jun 2013
234
Share Video

0:48
*******www.childrenshealthfund****/about-us/corporate-council/david-pulman - David Pulman took up the position of President, Global Manufacturing and Supply (GMS), GlaxoSmithKline in December 2002. He is a member of the Corporate executive team. Previously, he held the position of Senior Vice President - Strategy, Logistics and North American Supply, GMS, GSK, since January 2001.
15 Jun 2013
249
Share Video

3:39
Everyone is looking for a nice save haven in these dark and turbulent times. And what could be safer than a pharmaceutical giant. Perhaps one traditionally safe share has been oversold in recent times and might be looking good for a morsel of money.
14 Feb 2008
905
Share Video

5:03
MadAboutOption High octane options fun with strategies and ideas based on Cramer's picks.
17 Jul 2008
192
Share Video

2:31
Ob Millionen von Diabetikern oder Tausende Leukämie-Erkrankte: Weltweit kann vielen Pa-tienten mit biotechnologisch hergestellten Medikamenten geholfen werden. Die Forscher von GlaxoSmithKline sind weltweit neuen Therapiemöglichkeiten mit biopharmazeutisc
27 May 2009
188
Share Video

0:42
********twitter****/DavidPulman - In a perfect world, the organisation you work for should be world class at developing people. The world is not perfect. Notwithstanding this, the lead stakeholder in your development plan is you – not your company. No matter how good the development environment around you – if you do not take personal ownership of your development, then whatever future opportunities appear or fail to appear – then that is down to you!
15 Jun 2013
228
Share Video

1:17
First New Class of Topical Antibacterials in Nearly Two Decades GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection. Altabax represents the first new class of prescription topical antibacterials to be approved by the FDA in nearly two decades. Altabax is indicated for use twice daily for a five-day period in patients nine months of age and older. Other prescription topical antibacterials are used as much as three times daily for up to 12 days. "The introduction of Altabax comes at a time when antibiotic resistance is at an increasingly high level," said Stan Block, MD, President, Kentucky Pediatric and Adult Research Inc. "Altabax provides clinicians with a convenient new means to effectively fight the bacteria that cause impetigo through an effect that is different from other antibiotics. In vitro, this new topical antibiotic has shown a low potential for the development of resistance, possibly because it works in a unique manner compared to other antibiotics." Impetigo is a highly contagious infection of the top layers of the skin and is most common among infants and children ages 2 to 6 years. Children are especially susceptible to infections because their immune systems are still developing. Impetigo spreads easily in schools and child care settings, as well as anywhere groups of people are in close contact.
15 Apr 2007
2132
Share Video

2:10
Internet zum Hören - Das gibt es mit der Reihe Science Podcasts auch bei GlaxoSmithKline. In etwa 3-minütigen Filmbeiträgen werden ausgewählte Forschungsprojekte von GlaxoSmithKline vorgestellt. In der aktuellen Folge geht es um das Thema Forschung geg
9 Apr 2009
219
Share Video